News and Announcements
The Capital Raising Funnel
- Published December 20, 2022 2:41AM UTC
- Publisher Leila Oliveira
- Categories Capital Raising Tips
Is there any strategy to overcome the problem of investors not wanting to come in as a first investor?
Steve Torso answered in today’s webinar:
There are three steps to the process (either for marketing, capital raising or customer acquisition):
1) Awareness
2) Consideration
3) Decision
If you’re getting this response, it’s because you’re still in the first step.
In this case, step back and plan a strategy for your capital raising process and how you’ll bring momentum to the raise.
Don’t ask for money in this step.
Focus on building a relationship, and increasing the trust and respect between the investor and you. Then, you’d move to the next steps and close the deal.
Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.
Your capital engagement platform
With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.
Capital Raising Tips
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
